NCT04365023View on ClinicalTrials.gov

Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors

CompletedOBSERVATIONAL

Enrollment

168

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

May 25, 2023

Study Completion Date

May 25, 2023

Conditions

Neuroendocrine Tumors

Interventions

DRUG

platinum chemotherapy

First line platinum chemotherapy

Trial Locations (1)

75014

Gastroenterology and digestive oncology unit - Cochin hospital, Paris

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Ipsen

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER